PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
64 hedge funds and large institutions have $96.3M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
29% less call options, than puts
Call options by funds: $5K | Put options by funds: $7K
43% less capital invested
Capital invested by funds: $168M → $96.3M (-$71.8M)
Holders
64
Holding in Top 10
5
Calls
$5K
Puts
$7K
Top Buyers
| 1 | +$586K | |
| 2 | +$522K | |
| 3 | +$126K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63.2K |
| 5 |
Jane Street
New York
|
+$53K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$404K | |
| 3 | -$336K | |
| 4 |
Rafferty Asset Management
New York
|
-$332K |
| 5 |
5VM
5AM Venture Management
San Francisco,
California
|
-$188K |